These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 2016799

  • 1. Effect of magnesium on calcium oxalate urolithiasis.
    Su CJ, Shevock PN, Khan SR, Hackett RL.
    J Urol; 1991 May; 145(5):1092-5. PubMed ID: 2016799
    [Abstract] [Full Text] [Related]

  • 2. Effects of magnesium deficiency on intratubular calcium oxalate formation and crystalluria in hyperoxaluric rats.
    Rushton HG, Spector M.
    J Urol; 1982 Mar; 127(3):598-604. PubMed ID: 7062446
    [Abstract] [Full Text] [Related]

  • 3. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A.
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [Abstract] [Full Text] [Related]

  • 4. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.
    Schwille PO, Schmiedl A, Herrmann U, Fan J, Gottlieb D, Manoharan M, Wipplinger J.
    Urol Res; 1999 Apr; 27(2):117-26. PubMed ID: 10424393
    [Abstract] [Full Text] [Related]

  • 5. Metabolic Profile of Calcium Oxalate Stone Patients with Enteric Hyperoxaluria and Impact of Dietary Intervention.
    Siener R, Ernsten C, Welchowski T, Hesse A.
    Nutrients; 2024 Aug 13; 16(16):. PubMed ID: 39203825
    [Abstract] [Full Text] [Related]

  • 6. Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats.
    Pragasam V, Kalaiselvi P, Sumitra K, Srinivasan S, Varalakshmi P.
    Clin Chim Acta; 2005 Oct 13; 360(1-2):141-50. PubMed ID: 15992786
    [Abstract] [Full Text] [Related]

  • 7. Control of urinary risk factors of stones by betulin and lupeol in experimental hyperoxaluria.
    Vidya L, Varalakshmi P.
    Fitoterapia; 2000 Sep 13; 71(5):535-43. PubMed ID: 11449502
    [Abstract] [Full Text] [Related]

  • 8. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
    Milliner DS, Wilson DM, Smith LH.
    Kidney Int; 2001 Jan 13; 59(1):31-6. PubMed ID: 11135054
    [Abstract] [Full Text] [Related]

  • 9. Effects of magnesium salts in preventing experimental oxalate urolithiasis in rats.
    Ogawa Y, Yamaguchi K, Morozumi M.
    J Urol; 1990 Aug 13; 144(2 Pt 1):385-9. PubMed ID: 2374212
    [Abstract] [Full Text] [Related]

  • 10. Effect of dietary calcium and magnesium on experimental renal tubular deposition of calcium oxalate crystal induced by ethylene glycol administration and its prevention with phytin and citrate.
    Ebisuno S, Morimoto S, Yoshida T, Fukatani T, Yasukawa S, Ohkawa T.
    Urol Int; 1987 Aug 13; 42(5):330-7. PubMed ID: 3433579
    [Abstract] [Full Text] [Related]

  • 11. Effect of L-cysteine on some urinary risk factors in experimental hyperoxaluric rats.
    Saravanan N, Senthil D, Varalakshmi P.
    Br J Urol; 1996 Jul 13; 78(1):22-4. PubMed ID: 8795394
    [Abstract] [Full Text] [Related]

  • 12. A polyherbal formulation attenuates hyperoxaluria-induced oxidative stress and prevents subsequent deposition of calcium oxalate crystals and renal cell injury in rat kidneys.
    Bodakhe KS, Namdeo KP, Patra KC, Machwal L, Pareta SK.
    Chin J Nat Med; 2013 Sep 13; 11(5):466-71. PubMed ID: 24359768
    [Abstract] [Full Text] [Related]

  • 13. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature.
    Khan SR, Hackett RL.
    Scan Electron Microsc; 1985 Sep 13; (Pt 2):759-74. PubMed ID: 3901237
    [Abstract] [Full Text] [Related]

  • 14. Magnesium excretion and calcium oxalate urolithiasis.
    Resnick MI, Munday D, Boyce WH.
    Urology; 1982 Oct 13; 20(4):385-9. PubMed ID: 7147507
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.
    Noori N, Honarkar E, Goldfarb DS, Kalantar-Zadeh K, Taheri M, Shakhssalim N, Parvin M, Basiri A.
    Am J Kidney Dis; 2014 Mar 13; 63(3):456-63. PubMed ID: 24560157
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.